October 4, 2024
New York State has confirmed its first human case of eastern equine encephalitis (EEE) since 2015, according to a press release from the New York State […]
October 4, 2024
Wildfire-related air pollution in Europe kills more than non-wildfire air pollution. As climate change exacerbates the frequency and violence of wildfires, researchers are studying the health […]
October 4, 2024
HUNTINGTON BEACH, California — When patients of Aaron Mangold, MD, first learn they have mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma […]
October 4, 2024
Reference #: FEI 1950348 Product: Drugs Recipient: Recipient Name Mr. Richard A. Gilbert Recipient Title President Marcus Research Laboratory, Inc. 1820 Delmar Blvd.St. Louis, MO 63103United […]
October 4, 2024
Delivery Method: UPS Product: Drugs Recipient: Recipient Name Mr. Richard A. Gilbert Recipient Title President Marcus Research Laboratory, Inc. 1820 Delmar BoulevardSaint Louis, MO 63103United States […]
October 4, 2024
Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Larry Mills Recipient Title President Organa International Corp. 533 N 1650 WSpringville, UT 84663United States […]
October 4, 2024
RIO DE JANEIRO — Adding isatuximab, or Isa (Sarclisa, Sanofi-Aventis), to bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of patients with newly diagnosed, transplant-ineligible multiple […]
October 4, 2024
TOPLINE: Temtokibart, a novel monoclonal antibody, appears to achieve clinical improvements in moderate to severe atopic dermatitis (AD) by normalizing the skin barrier and increasing hydration, […]
October 4, 2024
An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here’s […]